Description
GLUCOWELL-MET 50/1000 mg Tablets (28’s)
GLUCOWELL-MET 50/1000 mg Tablets are a fixed-dose combination of Sitagliptin (50 mg) and Metformin Hydrochloride (1000 mg), designed for the effective management of type 2 diabetes mellitus. This dual therapy is indicated for patients who require more intensive glycemic control than can be achieved with metformin alone.
Sitagliptin, a DPP-4 inhibitor, enhances the body’s incretin system to stimulate insulin release and suppress glucagon secretion in response to meals. Metformin works by reducing hepatic glucose output and improving insulin sensitivity. Together, they address multiple mechanisms of glucose regulation, helping to control both fasting and postprandial blood sugar levels.
GLUCOWELL-MET is typically prescribed in combination with dietary modifications and regular physical activity. The 28-tablet pack provides a convenient four-week supply for once-daily or divided dosing, depending on clinical need.
Key Features:
-
Combines Sitagliptin 50 mg + Metformin 1000 mg for enhanced glycemic control
-
Dual-action approach: boosts insulin response and reduces liver glucose production
-
Suitable for patients not adequately controlled with metformin alone
-
Low risk of hypoglycemia and weight-neutral profile
-
Ideal for long-term management of type 2 diabetes
-
28-tablet pack supports consistent treatment adherence
Always use under the guidance of a healthcare professional as part of a complete diabetes management plan.
Reviews
There are no reviews yet.